Abstract
Objective: Human Papillomavirus (HPV) 6 and 11 are the aetiological agents responsible for Recurrent Respiratory Papillomatosis (RRP). There is general consensus that HPV11 results in more aggressive disease compared to HPV6. Method: Pubmed was searched using the terms respiratory papillomatosis, HPV 6 and HPV11. Comparisons were made in the outcomes of HPV6 versus HPV11 positive RRP disease. Results: There are numerous sub-types or variants of both HPV6 and HPV11. These sub-types have different activities at least in-vitro. The numbers of different HPV types within RRP tissue may be more extensive than initially appeared. This depends specifically upon the HPV types tested for. Conclusion: The clinical differences between HPV6 and HPV11 disease may not be accurately predictable as these viruses exist in numerous sub-types. Also, RRP tissue may contain more than one subtype or even be co-infected with other viruses that may influence outcome. In-vitro studies upon cell lines are a reasonable starting point for evaluation of these differences. © 2009 Elsevier Ireland Ltd. All rights reserved.
Original language | English |
---|---|
Pages (from-to) | 7-14 |
Number of pages | 7 |
Journal | International journal of pediatric otorhinolaryngology |
Volume | 74 |
Issue number | 1 |
DOIs | |
Publication status | Published - Jan 2010 |
Keywords
- HPV11
- HPV6
- Human Papillomavirus (HPV)
- Recurrent Respiratory Papillomatosis